logo image
search icon
Emerging Infectious Disease Diagnostics Market

Emerging Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report By Application (Laboratory Testing and Point-of-Care Testing), Technology, Type of Infection, Disease Type, End Users, Region, And Segment Forecasts, 2023-2031

Report ID : 2270 | Published : 2023-12-12 | Pages: 180 | Format: PDF/EXCEL

Emerging Infectious Disease Diagnostics Market Size is valued at US$ 19.23 Bn in 2022 and is predicted to reach US$ 31.76 Bn by the year 2031 at an 5.9% CAGR during the forecast period for 2023-2031.

Emerging Infectious Disease Diagnostics Market

Infectious disease diagnosis is a diagnostic procedure in which various diagnostic tools are used to detect and characterise the causative organisms of infectious diseases.

The COVID-19 pandemic certainly affected the market for infectious disease diagnostics. The COVID-19 pandemic has surged the need to develop diagnostic instruments and tests. For instance, in March 2023, QuidelOrtho Corporation received a De Novo Food and Drug Administration (FDA) Authorization for Sofia® 2 SARS Antigen+ FIA. The Sofia 2 SARS Antigen+ FIA is the first rapid antigen test that detects COVID-19. Additionally, in March 2020, BioMedomics introduced a COVID-19 point-of-care (POC) test that can identify antibodies in blood within 15 minutes.

Growth of the infectious disease diagnostics market is mainly driven by the increasing occurrence of infectious diseases such as COVID-19, human immunodeficiency virus (HIV), hepatitis, and influenza, high demand for point-of-care diagnostic tests, technological advancement in the healthcare sector, and rising government funding for diagnostic services. However, the lack of adequate reimbursements and high healthcare costs hamper the growth of the infectious disease diagnostics market. 

Competitive Landscape

Some of the Key Players in the Emerging Infectious Disease Diagnostics Market :

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Co-Diagnostics, Inc.
  • DANAHER CORPORATION
  • DiaSorin S.p.A.
  • Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • T2 Biosystems, Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Other Prominent Players

Market Segmentation:

The Emerging Infectious Disease Diagnostics Market is segmented based on application, technology, type of infection, disease type, and end users. The application segment comprises laboratory testing and point-of-care testing. By technology, the market is segregated into polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), next-generation sequencing (NGS), immunodiagnostics, and other technologies. By type of infection, the market is categorized into bacterial, viral, fungal, and other infections. The market is classified by disease type into respiratory infections, sexually transmitted infections (STIs), gastrointestinal infections, and other infections. The end users segment has been grouped into hospitals & clinics, diagnostic laboratories, and other end users.

By Application, The Point-Of-Care Testing Segment Records Significant Growth Over The Forecast Period.

Point-of-care (POC) testing for infectious diseases enables immediate & rapid detection and decision-making. POC tests are designed to be simple, easy to use, and suitable for use in many clinical settings. It facilitates diagnosis and timely decision-making with rapid results, often within minutes or hours; this is especially important for infectious diseases, improving patient outcomes and preventing further transmission.

POC tests can help reduce the spread of disease in the region by providing timely and accurate disease detection in resource-constrained environments.

The Next-Generation Sequencing (NGS) Segment Is Expected To Drive The Emerging Infectious Disease Diagnostics Market In The Upcoming Years.

Next-generation sequencing (NGS) has transformed the diagnosis of infectious diseases by enabling high-throughput analysis of genomes. Whole Genome Sequencing (WGS) sequences an organism's entire genome, providing detailed information about genetic mutations, immune responses, and other diseases. It can identify and characterize pathogens, monitor infections, and analyze evolutionary patterns. Other emerging technologies expected to experience significant growth include technologies such as polymerase chain reaction (PCR) and isothermal nucleic acid amplification technology (INAAT).

Bacterial And Viral Infections Register The Highest Growth In The Market.

There are many methods and techniques for detecting the presence of bacteria in clinical specimens. Bacterial infections include respiratory infections such as streptococcal infections and tuberculosis and sexually transmitted infections (STIs) such as syphilis, chlamydia, and gonorrhoea.

Viruses are capable of mutating and, therefore, can cause relapse even after one strain of the virus has been eradicated or brought under control. That's why molecular testing companies focus on developing tests that can diagnose a huge range of viruses. Some common viral infections include COVID-19, hepatitis, influenza, genital herpes, tuberculosis, gastroenteritis, rubella, Zika, Ebola, and others.

Respiratory Infections Are Expected To Lead The Market.

Most molecular diagnostic companies offer tools or tests for detecting bacteria & viruses that cause respiratory diseases. In addition, the COVID-19 outbreak has led manufacturers to develop many tests using traditional & advanced methods such as RT-PCR and modern technologies like RT-LAMP and CRISPR. Many pharmaceutical companies now offer multiplex assays that simultaneously detect respiratory syncytial virus (RSV), influenza A, influenza B, and SARS-CoV-2 in a single assay test.

By End Users, The Hospitals And Clinics Witnessed Growth At A Rapid Rate.

Hospitals and clinics play a key role in the diagnosis of infectious diseases and serve as important centres for patient evaluation and testing. In addition to point-of-care testing (POCT), which provides immediate results for rapid diagnosis and management, hospitals and clinics can rely on laboratory testing for comprehensive analysis. Some medical facilities have their own laboratories equipped with the most modern diagnostic technology, and others cooperate with external diagnostic laboratories for specialised testing. These laboratory facilities use a variety of methods, including molecular techniques such as polymerase chain reaction (PCR)  and sequencing, to accurately detect, classify, and analyse infectious agents.

Regionally, North America Led The Emerging Infectious Disease Diagnostics Market In 2022.

The North American emerging infectious disease diagnostics market is estimated to have significant market revenue during the forecast period due to the presence of key players, the high prevalence of infectious diseases, technological advancements in diagnostic instruments, and growing investments in the healthcare sector.

However, the emerging infectious disease diagnostics market in the Asia Pacific is anticipated to be the fastest-growing regional market in the upcoming years. Factors such as the expanding prevalence of infectious diseases, growing government spending in the health sector, well-established healthcare infrastructure, and rising awareness about advanced diagnostic tools contribute to market expansion.

Emerging Infectious Disease Diagnostics Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 19.23 Bn

Revenue Forecast In 2031

USD 31.76 Bn

Growth Rate CAGR

CAGR of 5.9 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Application, Technology, Type of Infection, Disease Type, End Users

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Abbott Laboratories, Becton, Dickinson and Company, bioMérieux S.A., Bio-Rad Laboratories, Inc., Co-Diagnostics, Inc., DANAHER CORPORATION, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Hologic, Inc., QIAGEN N.V., QuidelOrtho Corporation, T2 Biosystems, Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Siemens Healthineers AG, and Others.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Emerging Infectious Disease Diagnostics Market Snapshot

Chapter 4. Global Emerging Infectious Disease Diagnostics Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis of Metaverse Industry

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. COVID-19 Impact on Metaverse Industry

Chapter 5. Market Segmentation 1: By Application Estimates & Trend Analysis

5.1. By Application & Market Share, 2019-2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Application:

5.2.1. Laboratory Testing

5.2.2. Point-of-Care Testing

Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis

6.1. By Technology & Market Share, 2019-2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Technology:

6.2.1. Polymerase Chain Reaction (PCR)

6.2.2. Isothermal Nucleic Acid Amplification Technology (INAAT)

6.2.3. Next-Generation Sequencing (NGS)

6.2.4. Immunodiagnostics

6.2.5. Other Technologies

Chapter 7. Market Segmentation 3: By Type of Infection Estimates & Trend Analysis

7.1. By Type of Infection & Market Share, 2019-2031

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Type of Infection:

7.2.1.1. Bacterial

7.2.1.2. Viral

7.2.1.3. Fungal

7.2.1.4. Other Infections

Chapter 8. Market Segmentation 4: By Disease Type Estimates & Trend Analysis

8.1. By Disease Type & Market Share, 2019-2031

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Disease Type:

8.2.1. Respiratory Infections

8.2.2. Sexually Transmitted Infections (STIs)

8.2.3. Gastrointestinal Infections

8.2.4. Other Infections

Chapter 9. Market Segmentation 5: By End-User Estimates & Trend Analysis

9.1. By End-User & Market Share, 2019-2031

9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By End-User:

9.2.1.1. Hospitals and Clinics

9.2.1.2. Diagnostic Laboratories

9.2.1.3. Other End-Users

Chapter 10. Emerging Infectious Disease Diagnostics Market Segmentation 4: Regional Estimates & Trend Analysis

10.1. North America

10.1.1. North America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031

10.1.2. North America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031

10.1.3. North America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Type of Infection, 2023-2031

10.1.4. North America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Disease Type, 2023-2031

10.1.5. North America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031

10.1.6. North America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts by country, 2023-2031

10.1.6.1. U.S.

10.1.6.2. Canada

10.2. Europe

10.2.1. Europe Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by Application, 2023-2031

10.2.2. Europe Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031

10.2.3. Europe Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Type of Infection, 2023-2031

10.2.4. Europe Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Disease Type, 2023-2031

10.2.5. Europe Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031

10.2.6. Europe Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by country, 2023-2031

10.2.6.1. Germany

10.2.6.2. Poland

10.2.6.3. France

10.2.6.4. Italy

10.2.6.5. Spain

10.2.6.6. UK

10.2.6.7. Rest of Europe

10.3. Asia Pacific

10.3.1. Asia Pacific Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by Application, 2023-2031

10.3.2. Asia Pacific Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031

10.3.3. Asia Pacific Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Type of Infection, 2023-2031

10.3.4. Asia Pacific Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Disease Type, 2023-2031

10.3.5. Asia Pacific Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031

10.3.6. Asia Pacific Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by country, 2023-2031

10.3.6.1. China

10.3.6.2. India

10.3.6.3. Japan

10.3.6.4. Australia

10.3.6.5. Rest of Asia Pacific

10.4. Latin America

10.4.1. Latin America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by Application, 2023-2031

10.4.2. Latin America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Technology , 2023-2031

10.4.3. Latin America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Type of Infection, 2023-2031

10.4.4. Latin America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Disease Type , 2023-2031

10.4.5. Latin America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031

10.4.6. Latin America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by country, (US$ Million) 2023-2031

10.4.6.1. Brazil

10.4.6.2. Rest of Latin America

10.5. Middle East & Africa

10.5.1. Middle East & Africa Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by Application, (US$ Million)

10.5.2. Middle East & Africa Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031

10.5.3. Middle East & Africa Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Type of Infection, 2023-2031

10.5.4. Middle East & Africa Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Disease Type, 2023-2031

10.5.5. Middle East & Africa Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031

10.5.6. Middle East & Africa Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by country, (US$ Million) 2023-2031

10.5.6.1. South Africa

10.5.6.2. GCC Countries

10.5.6.3. Rest of MEA

Chapter 11. Competitive Landscape

11.1. Major Mergers and Acquisitions/Strategic Alliances

11.2. Company Profiles

11.2.1. Intercontinental Exchange, Inc. (US),

11.2.2. Nasdaq, Inc. (US),

11.2.3. CME Group (US),

11.2.4. AirCarbon Exchange (ACX) (Singapore),

11.2.5. Carbon Trade Exchange (CTX) (UK),

11.2.6. Xpansiv (US),

11.2.7. Carbonplace (England),

11.2.8. Planetly (Germany),

11.2.9. Likvidi (UK),

11.2.10. Toucan (Germany),

11.2.11. BetaCarbon (Australia),

11.2.12. ClimateTrade (US),

11.2.13. Carbon Credit Capital (US),

11.2.14.  Flowcarbon (US),

11.2.15. Carbonex (UK)

 

Segmentation of Emerging Infectious Disease Diagnostics Market -

Emerging Infectious Disease Diagnostics Market By Application-

  • Laboratory Testing
  • Point-of-Care Testing

Emerging Infectious Disease Diagnostics Market Seg

Emerging Infectious Disease Diagnostics Market By Technology-

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Next-Generation Sequencing (NGS)
  • Immunodiagnostics
  • Other Technologies

Emerging Infectious Disease Diagnostics Market By Type of Infection-

  • Bacterial
  • Viral
  • Fungal
  • Other Infections

Emerging Infectious Disease Diagnostics Market By Disease Type-

  • Respiratory Infections
  • Sexually Transmitted Infections (STIs)
  • Gastrointestinal Infections
  • Other Infections

Emerging Infectious Disease Diagnostics Market By End Users -

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Other End Users

Emerging Infectious Disease Diagnostics Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Emerging Infectious Disease Diagnostics Market?

Emerging Infectious Disease Diagnostics Market expected to grow at an 5.9% CAGR during the forecast period for 2023-2031.

QuidelOrtho Corporation, T2 Biosystems, Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Siemens Healthineers AG, and Others.

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Biotechnology

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach